Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-04.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 82

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 83
The Treatment Results of Childhood RhaMomyosarcoma

Journal of the Korean Pediatric Society 1992;35(11):1520-1527.
Published online November 15, 1992.
The Treatment Results of Childhood RhaMomyosarcoma
Chuhl-Joo Lyu1, Byung Soo Kim1, Eui Ho Hwang2, Chang Ok Suh3, Woo-Hee Cung4
1Department of Pediatrics, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
2Department of General Surgery, Yonsei University College of Medicine, Seoul, Korea
3Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea
4Department of Parthology, Yonsei University College of Medicine, Seoul, Korea
소아 횡문근육종의 치료 결과
유철주1, 김병수1, 황의호2, 서창옥3, 정우희4
1연세대학교 의과대학 소아과학교실, 연세암센터
2연세대학교 의과대학 외과학교실
3연세대학교 의과대학 치료방사선과학교실
4연세대학교 의과대학 병리학교실
Abstract
Rhabdomyosarcoma is a relatively common solid tumor in infants, children and adolescents, according for 4% to 8% of malignant disease in children less than 15 years old. Use of a multimodal approach to treatment has resulted in a dramatic improvement. Yonsei Cancer Center in Korea, since it's establishment in 1975, has been a state of multimodal approach. Thirty-seven cases of childhood rhabdomyosarcoma registered and followed-up at Yonsei Cancer Center, between Januay 1980 and December 1989 were analysed retrospectively. All patients were assigned to one of four clinical groups on the basis of extent of disease. The number of cases for Group I, II, III and IV was 3(8%), 7(19%), 21(57%) and 6(16%) respectively. There were relatively small number of cases with total tumor removel (Group I and II). Among the registered patients, there were cases of no proper treated after diagnosed. The results of treatment as follows: three year survival rate for Group I, II and III was 67%, 43% and 48% respectively. Two year survival rate for Group IV was 17% but none was survived at three year of follow-up period. There were seventeen registered patients who were completely treated by recommended therapeutic plans. Three year survival rate of this patients by Group I, II and III was 100% (2 patients), 67% and 73% respectively.
Key Words: Childhood rhaMomyosarcoma


METRICS Graph View
  • 1,835 View
  • 3 Download